PI3K |
Phosphatidylinositol3-kinase |
AKT |
Protein kinase B |
mTOR |
Mechanistic target of rapamycin |
MAPK |
Mitogen-activated protein kinase |
ERK |
Extracellular-regulated protein kinases |
JNK |
C-Jun N-terminal kinase |
NFκB |
Nuclear factor kappa-B |
SBP |
Scutellaria barbata polysaccharide |
GC-MS |
Gas chromatography–mass spectrometry |
PLK1 |
Polo-like kinase 1 |
TP53 |
Tumor protein p53 |
BAX |
BCL2-associated X |
P21 |
Protein 21 |
HepG2 |
Human hepatocellular carcinomas |
Bax |
BCL2-associated X |
Bcl |
B-cell lymphoma-2 |
CNE |
Human nasopharyngeal cancer cell |
SBD |
Scutellaria barbata D. Don |
VEGFA |
Vascular endothelial growth factor A |
p-EGFR |
p-Epidermal growth factor receptor |
PDE7B |
cAMP-specific 3′,5′-cyclic phosphodiesterase 7B |
PTHrP |
Parathyroid-hormone-related protein |
HD-SB |
Hedyotis diffusa–Scutellaria barbata
|
Smad |
Drosophila mothers against decapentaplegic protein |
MMP |
Matrix metalloproteinase |
EMT |
Epithelial–mesenchymal transition |
EGFR |
Epidermal growth factor receptor |
HUVEC |
Human umbilical vein endothelial cells |
ROS |
Reactive oxygen species |
LMO1 |
LIM domain only 1 |
PFS |
Progression-free survival
|
OS |
Overall survival |